HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate 2in1 Toothpaste/Mouthwash Combo Opens New Oral Care Category

This article was originally published in The Tan Sheet

Executive Summary

Colgate 2in1 Toothpaste and Mouthwash, which combines ingredients from both products in a light, foaming gel, will be launched in September, Colgate-Palmolive announced July 5. Ads from Young & Rubicam will break in November. Other promotional plans include sampling, Internet-based programs and direct mail.

You may also be interested in...



Colgate Total Advanced Fresh 2in1 To Expand Liquid Gel Toothpaste Line

Colgate-Palmolive is planning another extension of the Colgate Total line with the February launch of Advanced Fresh 2in1 Toothpaste

Colgate 2in1

TV spot, FSI claim combination toothpaste/mouthwash "Kills the germs that cause bad breath." TV ad, which broke Nov. 13, calls newest Colgate product "Pure genius" and features an artist throwing toothpaste and mouthwash at a canvas, revealing an image of a bottle of Colgate 2in1. FSI carries a $1-off coupon for Fresh Mint, Tartar Control or Whitening flavors of the product, which shipped in September (1"The Tan Sheet" July 10, p. 8)

Colgate Three-Year Product Pipeline Includes 100+ Screened Items

Almost 60% of Colgate-Palmolive's 1999 U.S. sales came from products launched in the last five years, Colgate Executive Vice President & North America President Ian Cook reported at a Morgan Stanley Dean Witter conference in New York City Nov. 9.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133611

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel